PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS.

MLA

Vieira, Fernando G., et al. “PERK Modulation, with GSK2606414, Sephin1 or Salubrinal, Failed to Produce Therapeutic Benefits in the SOD1G93A Mouse Model of ALS.” PloS One, vol. 19, no. 2, Feb. 2024, p. e0292190. EBSCOhost, https://doi.org/10.1371/journal.pone.0292190.

APA

Vieira, F. G., Tassinari, V. R., Kidd, J. D., Moreno, A., Thompson, K., Perrin, S., Gill, A., & Hatzipetros, T. (2024). PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS. PloS One, 19(2), e0292190. https://doi.org/10.1371/journal.pone.0292190

Chicago

Vieira, Fernando G, Valerie R Tassinari, Joshua D Kidd, Andrew Moreno, Kenneth Thompson, Steven Perrin, Alan Gill, and Theo Hatzipetros. 2024. “PERK Modulation, with GSK2606414, Sephin1 or Salubrinal, Failed to Produce Therapeutic Benefits in the SOD1G93A Mouse Model of ALS.” PloS One 19 (2): e0292190. doi:10.1371/journal.pone.0292190.